Current anti-inflammatory agents pose risks of autoimmune responses and weakened immune defenses, necessitating safer and more effective alternatives.
The invention presents novel coumarin-based lignan compounds as potential therapeutic agents for treating chronic inflammatory conditions.
The invention provides specific chemical compounds and processes for their synthesis, along with their use as anti-inflammatory agents and in pharmaceutical compositions for treating inflammatory diseases.
Potential Indian Clients: Pharmaceutical companies focusing on research and development of anti-inflammatory drugs, contract research organizations (CROs) offering synthesis services
Current TRL: NA
Funded by: NA
IPC: C07C
Domain: Pharmaceutical Chemistry, Therapeutics
This website uses cookies or similar technologies, to enhance your browsing experience.